Arc reveals Evo 2's novel genomic design capabilities
Evo 2 generates functional DNA and proteins using few-shot learning and reinforcement learning, accelerating biological research workflows significantly.
See the latest news and media coverage for Arc. We track all announcements, press releases, and industry mentions in real time, all in one place.
Nonprofit research organization for AI and biology
arcinstitute.orgLast updated
In short: Arc advanced AI-driven biology through virtual cell models, AI-designed genomes, and new leadership.
Evo 2 generates functional DNA and proteins using few-shot learning and reinforcement learning, accelerating biological research workflows significantly.
The tool identifies unexplored RNA sequences and CRISPR systems, providing a public database for molecular discovery.
They used fine-tuned genome language models, custom annotation, and high-throughput assays to design and validate 16 functional ΦX174-like phages that maintained host specificity and overcame resistant E. coli.
The funding supports Arc's Virtual Cell Initiative to build AI models predicting cellular responses for disease research. It enables scaled datasets, model training, validation in Alzheimer's, and open access.
Tests of unguarded systems show why that possibility troubles experts.
The work builds on Evo 1 and Evo 2, two AI models developed for working with biological sequences. Evo 2, developed by the Arc Institute...
Researchers used AI to design viable virus genomes. The method offers opportunities against resistant germs, but also risks for biosafety.
Circle’s Arc will launch with opt-in quantum-resistant wallets, making it one of the first blockchains designed from scratch for a post-quantum future.
Track Arc and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Arc and other trending companies.